Association of Selective Serotonin Reuptake Inhibitors With the Risk of Type 2 Diabetes in Children and Adolescents

In US paediatric cohort study of more than 1 million patients, initiation of SSRI was linked to small increased risk of type 2 diabetes (HR 1.13; 95% CI, 1.04-1.22 among publicly insured patients) but magnitude was more modest than previously reported, and absolute risk was small


JAMA Psychiatry